Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N04BC05	SIFROL	B	Pramipexole (dihydrochloride monohydrate) - 0.7mg	0.7mg	Tablet	2,478,046 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.75mg	0.75mg	Tablet, extended release	942,034 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.375mg	0.375mg	Tablet, extended release	473,033 L.L
N04BC05	SIFROL	B	Pramipexole (dihydrochloride monohydrate) - 0.18mg	0.18mg	Tablet	631,606 L.L
J07AL02	SYNFLORIX	B	Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg		Injectable suspension	4,675,228 L.L
A03A	SPASMOBROM	B	Pipethanate Ethobromide - 20mg	20mg	Tablet, coated	705,517 L.L
A03AX12	SPASFON	B	Phloroglucinol hydrate - 80mg, Trimethylphloroglucinol - 80mg		Tablet, coated	278,175 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.9mg/ml	0.9mg/ml	Injectable solution	191,126,390 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.6mg/ml	0.6mg/ml	Injectable solution	187,497,407 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.3mg/ml	0.3mg/ml	Injectable solution	175,400,801 L.L
N06AB05	SEROXAT CR	B	Paroxetine (HCl) - 25mg	25mg	Tablet, controlled release	2,845,587 L.L
N06AB05	SEROXAT	B	Paroxetine (HCl) - 20mg	20mg	Tablet, film coated	1,586,205 L.L
N06AB05	SEROXAT CR	B	Paroxetine (HCl) - 12.5mg	12.5mg	Tablet, controlled release	2,371,608 L.L
N02BE01	SULDEX A	G	Paracetamol - 600mg	600mg	Suppository	200,936 L.L
N02BE51	SICADOL EXTRA	G	Paracetamol - 500mg, Caffeine - 65mg		Tablet	147,823 L.L
N02BE51	SOLPADEINE	B	Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg		Tablet	319,835 L.L
N02BE51	SOLPADEINE SOLUBLE	B	Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg		Tablet, effervescent	326,554 L.L
N02BE51	SOLPEX	G	Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg		Tablet	243,172 L.L
N02BE01	SULDEX 250	G	Paracetamol - 250mg	250mg	Suppository	127,985 L.L
N02BE01	STOPALGIC	G	Paracetamol - 1g/100ml	1g/100ml	Injectable solution	1,536,012 L.L
N02BE01	SOLUFLEX PARACETAMOL	G	Paracetamol - 1g/100ml	1g/100ml	Injectable solution	211,175 L.L
N02BE01	SULDEX B	G	Paracetamol - 150mg	150mg	Suppository	117,746 L.L
N02BE01	SULDEX 125	G	Paracetamol - 125mg	125mg	Suppository	110,067 L.L
N02BE01	SUPOFEN	G	Paracetamol - 10mg/ml	10mg/ml	Injectable solution	7,675,286 L.L
N02BE01	SICADOL	G	Paracetamol - 1000mg	1000mg	Tablet	423,310 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	38,316,693 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 100mg/ml	100mg/ml	Injectable solution	57,429,464 L.L
A03AB06	SPASMOMEN	B	Otilonium bromide - 40mg	40mg	Tablet, film coated	438,093 L.L
A02BC01	SANAMIDOL	G	Omeprazole - 20mg	20mg	Capsule	456,906 L.L
A02BC01	STOMAZOLE	G	Omeprazole - 20mg	20mg	Capsule	593,850 L.L

...